Towards Healthcare
Inflammatory Bowel Disease Treatment Market Size Envisioned at USD 33.19 Bill...

Inflammatory Bowel Disease Treatment Market Size Envisioned at USD 33.19 Billion by 2032

The report covers Inflammatory Bowel Disease (IBD) Treatment Market Size, Companies and Segmentations into Crohn's Disease and Ulcerative Colitis, with treatment options including Corticosteroids, Aminosalicylates, TNF Inhibitors, IL Inhibitors, JAK Inhibitors, Anti-Integrin Medications and others. These treatments can be administered orally or via injection and they are typically distributed through hospital, retail and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • AbbVie Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Takeda Pharmaceutical Company Limited.
  • Pfizer Inc.
  • Biogen
  • Novartis AG
  • Eli Lilly and Company
  • UCB S.A.
  • CELLTRION INC.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.

Conclusion & Recommendations

  • Insight Code: 5149
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

Talk to us
FAQ's

The expiry of patents for some TNF inhibitor drugs is leading to the introduction of biosimilars. These offer similar efficacy at lower costs, potentially increasing market access for patients and putting pressure on traditional drug prices.

The market is witnessing the rise of new treatment classes like JAK inhibitors, offering alternative options for patients. Additionally, there is growing interest in personalized medicine approaches, tailoring therapy based on individual patient needs and response to specific medications.

High costs of medications, limited access to new therapies in certain regions, and the need for continued development of even more effective and personalized treatment options remain key challenges in the IBD treatment market.

Food and Drug Administration, National Institute of Health, CROHNS & COLITIS FOUNDATION, The Department of Health, State Government of Victoria, Australia.
Any Questions